36 channel-coding-electrical-engineering Postdoctoral positions at Nature Careers in Germany
Sort by
Refine Your Search
-
to your scientific expertise to work within the German Research Foundation (DFG) funded project “Multi-channel transcranial current stimulation (mc-tCS): a novel approach to modulate smooth pursuit eye
-
on Clostridium carboxidivorans and Clostridium ljungdahlii, for which we have already established robust genetic and process engineering platforms. The following publications illustrate the potential and direction
-
Area of research: Scientific / postdoctoral posts Job description: Postdoc in Prophage Engineering (f/m/x) 102786 Full time 39 hrs./week Neuherberg near Munich Partial Home Office possible
-
Area of research: Scientific / postdoctoral posts Job description: Researcher - Engineering & Physics for Biomedical Innovations (f/m/x) 102788 Full time 39 hrs./week Neuherberg near Munich
-
Engineering / Discovery start at the earliest possible date The goal of this project is to engineer existing biosynthetic pathways encoding for natural products, such as antimicrobial peptides (AMPs, RiPPs
-
Postdoc Pathways) If you enjoy working in a very collaborative, supportive and international team, you love writing and improving code, you like analytical thinking and constructive problem-solving, and you
-
employment (subject to release of funds) The Bundesanstalt für Materialforschung und -prüfung (BAM) is a materials research organization in Germany. Our mission is to ensure safety in technology and chemistry
-
elucidation, with the aim of understanding their function and dynamic mechanism. One key focus lies on the understanding of neuronal ion channels, their regulation through other proteins, small molecules and
-
within this project include: Extending DeepRVAT towards non-coding genetic variation Applying DeepRVAT to population-scale single-cell readouts Integrating population data with experimental perturbation
-
alters immune responses against vaccines using next-generation human tissue and organoid models. Current vaccines against infectious diseases and cancer benefit only a subset of patients, partly due to our